Ocular surface diseases (OSD) such as dry eye disease or anterior blepharitis have become more prevalent, causing visual disturbances, ocular discomfort in patients; however, these disorders continue to remain undiagnosed in majority of the populace. The evidence suggests that there is an increasing incidence of ocular allergies requiring long-term management.
In the past two decades, there has been an increased research focus on the underlying pathophysiology, diagnosis and treatment of these diseases. Novel biomarkers found in the tear fluid and alterations in the ocular microbiome are increasingly gaining recognition as possible diagnostic tools and hence gaining interest of research groups globally.
We are launching a collection focused on the debilitating chronic diseases of the ocular surface, with the aim to collate recent advances and to comprehensively review developments in OSD research.
We are particularly interested in research on the pathogenesis of OSD as well as in studies describing novel patient-centric treatment strategies. We will be considering both basic and clinical research but strongly encourage authors to submit their experimental work to this collection. We are also interested in high-quality systematic reviews and meta-analyses from this field.
Potential topics include but are not limited to the following:
● Advances in treatment of dry eye disease, Meibomian gland dysfunction and blepharitis
● Basic research focused on the pathophysiology of OSD
● Newer imaging modalities for clinical diagnostics of OSD
● Ocular surface and tear biomarkers
● OSD as the consequence of ophthalmic surgery
● The ocular microbiome
● Ocular surface and aging